800
Views
33
CrossRef citations to date
0
Altmetric
Original

Parental attitudes and involvement in psychopharmacological treatment for ADHD: A conceptual model

&
Pages 135-141 | Published online: 11 Jul 2009

References

  • Bussing R, Schoenberg NE, Perwien AR. Knowledge and information about ADHD: Evidence of cultural differences among African-American and white parents. Social Science and Medicine 1998; 46(7)919–928
  • Davison JC, Davison JC, Ford DY. Perceptions of attention deficit hyperactivity disorder in one African American community. Journal of Negro Education 2001; 70(4)264–274
  • dosReis S, Butz A, Lipkin P, Anixt J, Weiner CL, Chernoff R. Attitudes about stimulant medication for attention-deficit/hyperactivity disorder among African-American families in an inner city community. Journal of Behavioral Health Services & Research 2006; 33(4)423–430
  • dosReis S, Mychailyszyn MP, Myers MA, Riley AW. Coming to terms with ADHD: How urban African-American families come to seek care for their children. Psychiatric Services 2007; 58(5)636–641
  • dosReis S, Zito JM, Safer DJ, Soeken KL, Mitchell JW, Ellwood LC. Parental perceptions and satisfaction with stimulant medication for attention-deficit/hyperactivity disorder. Journal of Developmental and Behavioral Pediatrics 2003; 24(3)155–162
  • Eiraldi RB, Mazzuca LB, Clarke AT, Power TJ. Service utilization among ethnic minority children with ADHD: A model of help-seeking behavior. Administration and Policy in Mental Health & Mental Health Services Research 2006; 33(5)607–622
  • Jensen PS, Arnold LE, Swanson JM, Vitiello B, Abikoff HB, Greenhill LL, et al. Three-year follow-up of the NIMH MTA study. Journal of the American Academy of Child and Adolescent Psychiatry 2007; 46(8)989–1002
  • Krain AL, Kendall PC, Power TJ. The role of treatment acceptability in the initiation of treatment for ADHD. Journal of Attention Disorders 2005; 9(2)425–434
  • McHugh PR, Slavney PR. The perspectives of psychiatry2nd. The Johns Hopkins University Press, Baltimore 1998
  • McLeod JD, Pescosolido BA, Takeuchi DT, White TF. Public attitudes toward the use of psychiatric medications for children. Journal of Health and Social Behavior March, 2004; 45: 53–67
  • Meyer B, Pilkonis PA, Krupnick JL, Egan MK, Simmens SJ, Sotsky SM. Treatment expectancies, patient alliance, and outcome: Further analyses from the National Institute of Mental Health Treatment of Depression Collaborative Research program. Journal of Consulting and Clinical Psychology 2002; 70(4)1051–1055
  • MTA Cooperative Group. National Institute of Mental Health multimodal treatment study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics 2004; 113(4)754–761
  • Olaniyan O, dosReis S, Garriett V, Mychailyszyn MP, Anixt J, Rowe PC, et al. Community perspectives of childhood behavioral problems and ADHD among African American parents. Ambulatory Pediatrics 2007; 7(3)226–231
  • Pastor PN, Reuben CA. Racial and ethnic differences in ADHD and LD in young school-age children: parental reports in the National Health Interview Survey. Public Health Reports 2005; 120(4)383–392
  • Pescosolido BA, Perry BL, Martin JK, McLeod JD, Jensen PS. Stigmatizing attitudes and beliefs about treatment and psychiatric medications for children with mental illness. Psychiatric Services 2007; 58(5)613–618
  • Riddle MA, Geller B, Ryan N. Another sudden death in a child treated with desipramine. Journal of the American Academy of Child & Adolescent Psychiatry 1993; 32(4)792–797
  • Safer DJ, Zito JM, Gardner JF. Pemoline hepatotoxicity and post-marketing surveillance. Journal of the American Academy of Child and Adolescent Psychiatry 2001; 40(6)622–629
  • Sayal K, Taylor E, Beecham J. Parental perception of problems and mental health service use for hyperactivity. Journal of the American Academy of Child and Adolescent Psychiatry 2003; 42(12)1410–1414
  • Summers JA, Caplan PJ. Laypeople's attitudes toward drug treatment for behavioral control depend upon which disorder and which drug. Clinical Pediatrics 1987; 26(5)258–262

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.